VIIa/tissue factor interaction results in a tissue factor cytoplasmic domain-independent activation of protein synthesis, p70, and p90 S6 kinase phosphorylation.
about
Ovarian cancer, the coagulation pathway, and inflammationSpecificity of coagulation factor signalingTissue factor induces VEGF expression via activation of the Wnt/β-catenin signaling pathway in ARPE-19 cellsTissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells.Tissue factor-factor VIIa signaling.Essential role for the d-Asb11 cul5 Box domain for proper notch signaling and neural cell fate decisions in vivo.Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant miceThe cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia.Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathwaysDichotomy in Hedgehog signaling between human healthy vessel and atherosclerotic plaquesTissue factor as a novel target for treatment of breast cancerTranslating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific.Structure-Function Relationship of the Interaction between Tissue Factor and Factor VIIa.Kinome profiling.Tissue factor-Akt signaling triggers microvessel formation.Coagulation factors VIIa and Xa inhibit apoptosis and anoikis.E. coli-produced BMP-2 as a chemopreventive strategy for colon cancer: a proof-of-concept study.asb11 is a regulator of embryonic and adult regenerative myogenesis.Acute stress elicited by bungee jumping suppresses human innate immunityMajor remodelling of the murine stem cell kinome following differentiation in the hematopoietic compartment.Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain.Identification of the coagulation factor VIIa integrin binding site required for pro-angiogenic PAR2 signaling.Suppression of p21Rac signaling and increased innate immunity mediate remission in Crohn's disease.
P2860
Q24816796-66F841B8-31F5-4D53-82D5-5F8BFD33FD60Q28188159-68C76938-4888-4E0D-83DF-1D6BDFA5339AQ28828849-598B0C03-B2B4-467D-8DA5-8E34D643BA4BQ33322944-D2BFFBD8-1050-4A48-92FF-6440296E8AF5Q33726774-EBDA101E-CD46-4D49-834E-4A3518BBDC4FQ33761287-06069936-9B28-47E9-91E7-3B4E5E63AB56Q35083269-2206F756-1331-46A1-81C7-1D512EB7C86BQ35102893-EC6BC87B-2F6C-4833-9EEE-82B3669F990AQ35926915-6BC998B4-3E56-43E1-94DF-15275262B181Q36327368-18D852FB-7C31-4399-8E7F-5A9131568298Q36565603-FEAEC266-849F-4737-A8CA-4FC9F2922011Q36814213-B3E99740-6097-44CE-8D36-1B1B5B1CA50DQ36889043-7A17E9C5-7BA5-4AA7-91F3-1B94AA624C22Q38166360-314A7055-35AC-489A-AD7F-5FDA56A9F047Q39316471-8FB3C1A1-2159-414E-90AE-D0C3F7F88BFBQ40599210-224B7C31-7C49-4E32-8984-0DD34C5861A6Q40795458-054E80B7-323E-4538-8B2A-3874E9800B8AQ41254732-10DFAE56-208B-418B-94ED-84256460F016Q42024163-CDEA07E9-5056-467D-B0CE-9E44306E3895Q42857362-9D05D5B7-33AA-4FC3-BEC6-1BC863B1856FQ46573809-6F673021-9585-4BA9-A0F1-7CCD329173CAQ47287709-099B9C7E-D783-4B73-AF20-41D667A27D9FQ54357723-1588F241-A3F1-443B-9CD5-F4C5C59A5CFE
P2860
VIIa/tissue factor interaction results in a tissue factor cytoplasmic domain-independent activation of protein synthesis, p70, and p90 S6 kinase phosphorylation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
VIIa/tissue factor interaction ...... p90 S6 kinase phosphorylation.
@en
type
label
VIIa/tissue factor interaction ...... p90 S6 kinase phosphorylation.
@en
prefLabel
VIIa/tissue factor interaction ...... p90 S6 kinase phosphorylation.
@en
P2093
P2860
P356
P1476
VIIa/tissue factor interaction ...... p90 S6 kinase phosphorylation.
@en
P2093
Brit B Sørensen
Dick J Richel
Jan H M Van den Brande
Jord C Stam
Lars C Petersen
Paul M P van Bergen en Henegouwen
Sjoukje H Slofstra
P2860
P304
27065-27072
P356
10.1074/JBC.M110325200
P407
P577
2002-05-17T00:00:00Z